Braun Stacey Associates Inc Eli Lilly & CO Transaction History

Braun Stacey Associates Inc

$2.54 Billion
Q3 2024

A detailed history of Braun Stacey Associates Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Braun Stacey Associates Inc holds 55,614 shares of LLY stock, worth $44.3 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares

55,614

Previous 65,649 15.29%

Holding current value

$44.3 Million

Previous $59.4 Million 17.11%

% of portfolio

1.94%

Previous 2.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$772.14 - $960.02 $7.75 Million - $9.63 Million	-10,035 Reduced 15.29%	55,614 $49.3 Million
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $474,789 - $595,421	-655 Reduced 0.99%	65,649 $59.4 Million
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $177,660 - $237,684	-300 Reduced 0.45%	66,304 $51.6 Million
Q4 2023 Jan 23, 2024	SELL	$525.19 - $619.13 $2.77 Million - $3.26 Million	-5,265 Reduced 7.33%	66,604 $38.8 Million
Q3 2023 Nov 21, 2023	SELL	$434.7 - $599.3 $1.87 Million - $2.58 Million	-4,311 Reduced 5.66%	71,869 $38.6 Million
Q2 2023 Jul 28, 2023	SELL	$350.74 - $468.98 $27.3 Million - $36.5 Million	-77,814 Reduced 50.53%	76,180 $35.7 Million
Q1 2023 May 08, 2023	BUY	$310.63 - $364.82 $24 Million - $28.2 Million	77,415 Added 101.09%	153,994 $52.9 Million
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $554,995 - $646,680	-1,726 Reduced 2.2%	76,579 $28 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $323,163 - $368,278	-1,090 Reduced 1.37%	78,305 $25.3 Million
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $140,758 - $165,271	505 Added 0.64%	79,395 $25.7 Million
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $425,962 - $529,362	1,815 Added 2.35%	78,890 $22.6 Million
Q4 2021 Jan 25, 2022	BUY	$224.85 - $279.04 $742,904 - $921,948	3,304 Added 4.48%	77,075 $21.3 Million
Q3 2021 Dec 01, 2021	BUY	$221.6 - $272.71 $778,924 - $958,575	3,515 Added 5.0%	73,771 $17 Million
Q2 2021 Jul 23, 2021	BUY	$180.55 - $233.54 $475,207 - $614,677	2,632 Added 3.89%	70,256 $16.1 Million
Q1 2021 Apr 28, 2021	BUY	$164.32 - $212.72 $11.1 Million - $14.4 Million	67,624 New	67,624 $12.6 Million
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $218,520 - $289,155	-1,675 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $228,503 - $275,001	1,675 New	1,675 $275,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.

Account

Braun Stacey Associates Inc Eli Lilly & CO Transaction History